Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026.
- Largest single sale: $38.4M (1,400,000 shares) of Roivant Sciences Ltd. on Feb 19, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | President and Vant Chair | Jul 29, 2025 | Oct 2, 2026 |
| Immunovant, Inc. (IMVT) | Director | Dec 20, 2019 | Apr 9, 2026 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 30, 2026, Roivant Sciences Ltd.: 40,309 shares withheld by the company for taxes. 1 filing: 1
- Jun 30, 2026, Roivant Sciences Ltd.: 40,310 shares withheld by the company for taxes. 1 filing: 1
- Apr 7, 2026, Immunovant, Inc.: 174,189 shares granted. 1 filing: 1
- Mar 31, 2026, Roivant Sciences Ltd.: 160,035 shares withheld by the company for taxes. 1 filing: 1
- Feb 23, 2026, Roivant Sciences Ltd.: sold 587,390 shares for $16.2M, under a disclosed plan; 587,390 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.